Advertisement

Topics

AVAIL GmbH Company Profile

11:24 EST 22nd November 2017 | BioPortfolio

AVAIL is the bridge to get your message across easily and effectively when you need to attract attention to your projects and persuade your peers. Our team of specialists in medical writing and scientific communication is committed to serving customers' ends with competence and dedication. We are used to dealing with difficult tasks and can rapidly and reliably help you to deliver your message with impact, regardless of the complexity of your projects. Professionalism, proactivity and capability of working confidently under pressure contribute to the high quality and efficiency of our services.
The benefits of using AVAIL will be to produce successful documents and papers that people read and remember, improve your image, and sell your ideas and products while saving your time and internal resources.

Location

Spalentorweg 18
Basel
CH-4051
Switzerland

Contact

Phone: 41 61 262 3563
Fax: 41 61 262 3562
Email: info@avail.ch


News Articles [124 Associated News Articles listed on BioPortfolio]

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Evotec-Aktie: Q3/17 operativ beeindruckend - mehr Innovationen - Kaufen! Aktienanalyse

Frankfurt am Main - Evotec-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse weiterhin zum Kauf ....

Workout Templates for a Hot Summer Bod

(PRWEB) July 31, 2017 Many people dread the summertime, constantly searching for ways to improve their body to no avail. In fact, su...

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SE Unternehmen: Valneva SE ISIN: FR0004056851 Anlass der Studie: U...

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

Original-Research: Mologen AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Mologen AG Unternehmen: Mologen AG ISIN: DE0006637200 Anlass der Studie: Q...

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Dental and Oral Problem Patterns and Treatment Seeking Behavior of Geriatric Population.

The manifestations of oral changes and disorders affecting the geriatric population are different from the rest of the population. Inaccessibility to dental care is a compelling impediment to avail or...

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Clinical Trials [43 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma

The AVAIL-T trial is a trial to find out how effective avelumab is at treating patients with primary T-cell lymphoma that is refratory to or has relapsed following initial treatment.

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

The purpose of this study is to determine whether adding DIM supplement will decrease breast density among female BRCA mutation carriers in two years.

The Use of Oral Appliances as an Adjunct to Continuous Positive Airway Pressure (C-PAP) in the Treatment of Obstructive Sleep Apnoea

This study will look at whether patients with OSAHS already successfully treated with nasal CPAP could successfully use an oral appliance as a short-term treatment alternative and whether ...

Companies [523 Associated Companies listed on BioPortfolio]

AVAIL GmbH

AVAIL is the bridge to get your message across easily and effectively when you need to attract attention to your projects and persuade your peers. Our team of specialists in medical writing and scient...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "AVAIL GmbH" on BioPortfolio

We have published hundreds of AVAIL GmbH news stories on BioPortfolio along with dozens of AVAIL GmbH Clinical Trials and PubMed Articles about AVAIL GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AVAIL GmbH Companies in our database. You can also find out about relevant AVAIL GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record